Insider · CIK 0001324015
Jeffrey William Henderson
Files at BDX (BECTON DICKINSON & CO), QCOM (QUALCOMM INC/DE), HALO (HALOZYME THERAPEUTICS, INC.). First filing Jan 7, 2025, latest Apr 28, 2025.
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
HALO: HALOZYME THERAPEUTICS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
BDX: BECTON DICKINSON & CO
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 13Weak | HALOZYME THERAPEUTICS, INC. | $271k 4,497 shares | -14% | +42% from low-7% from high | |
| 0Weak | HALOZYME THERAPEUTICS, INC. | $32k 503 shares | -1% | +45% from low-5% from high | |
| 22Weak | HALOZYME THERAPEUTICS, INC. | $293k 5,000 shares | -13% | - | |
| 36Weak | BDXbuy BECTON DICKINSON & CO | $350k 1,500 shares | +23% | - | |
| 14Weak | HALOZYME THERAPEUTICS, INC. | $282k 5,000 shares | -11% | - | |
| 18Weak | HALOZYME THERAPEUTICS, INC. | $500k 10,000 shares | -19% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 1, 2025 | HALO HALOZYME THERAPEUTICS, INC. | AGrant or award Common Stock | +4,165 | $0.00 | $0 | 32,776 | May 2, 2025 |
| May 1, 2025 | HALO HALOZYME THERAPEUTICS, INC. | AGrant or award Option to Purchase Common Stockderivative | +5,750 | $0.00 | $0 | 5,750 | May 2, 2025 |
| Apr 28, 2025 | HALO HALOZYME THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -4,297 | $60.34 | $259k | 28,811 | Apr 28, 2025 |
| Apr 28, 2025 | HALO HALOZYME THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -200 | $61.00 | $12k | 28,611 | Apr 28, 2025 |
| Apr 1, 2025 | HALO HALOZYME THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -503 | $64.05 | $32k | 33,108 | Apr 1, 2025 |
| Mar 18, 2025 | QCOM QUALCOMM INC/DE | AGrant or award Common Stock | +2,097 | $0.00 | $0 | 10,406 | Mar 20, 2025 |
| Mar 9, 2025 | QCOM QUALCOMM INC/DE | MOption exercise Common Stock | +1,901 | $0.00 | $0 | 8,309 | Mar 10, 2025 |
| Mar 9, 2025 | QCOM QUALCOMM INC/DE | MOption exercise Deferred Stock Unitderivative | -1,901 | $0.00 | $0 | 3,938 | Mar 10, 2025 |
| Mar 3, 2025 | HALO HALOZYME THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -1,795 | $57.93 | $104k | 36,816 | Mar 3, 2025 |
| Mar 3, 2025 | HALO HALOZYME THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -3,205 | $59.12 | $189k | 33,611 | Mar 3, 2025 |
| Feb 10, 2025 | BDX BECTON DICKINSON & CO | POpen-market purchase Common Stock | +1,500 | $233.62 | $350k | 8,015 | Feb 10, 2025 |
| Feb 3, 2025 | HALO HALOZYME THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -1,100 | $55.94 | $62k | 42,511 | Feb 4, 2025 |
| Feb 3, 2025 | HALO HALOZYME THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -3,900 | $56.41 | $220k | 38,611 | Feb 4, 2025 |
| Jan 28, 2025 | BDX BECTON DICKINSON & CO | AGrant or award Common Stock | +930 | $0.00 | $0 | 6,515 | Jan 30, 2025 |
| Jan 6, 2025 | HALO HALOZYME THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -10,000 | $50.01 | $500k | 43,611 | Jan 7, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.